What's new

Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 24, Status: Authorised

Apr 3, 2025 - 15:57
 0
Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Perjeta, pertuzumab, Date of authorisation: 04/03/2013, Revision: 24, Status: Authorised
Read More

Tags:

Previous Article

Sector by sector: the Trump tariff fallout

Next Article

Trump guts LIHEAP, threatening $378M in energy assistance already approved by Co...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Opsumit, Macitentan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Cardiac disorders, PIP number: P/0457/2023

Opinion/decision on a Paediatric investigation plan (PI...

Mar 6, 2025  0

Agenda of the HMPC meeting 17-19 March 2025

Mar 13, 2025  0

Human medicines European public assessment report (EPAR): Ibandronic acid Accord, ibandronic acid, Date of authorisation: 18/11/2012, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0